InvestorsHub Logo
Followers 75
Posts 9164
Boards Moderated 0
Alias Born 04/25/2002

Re: Nosnibor post# 33646

Friday, 11/04/2022 1:13:13 AM

Friday, November 04, 2022 1:13:13 AM

Post# of 36577
FDA EUA approval is 100% linked to meeting the 'Primary Endpoints'. Absolutely NOTHING else matters.... no matter how good it is!!! Gotta meet the 'Primary Endpoints', or the FDA will reject it. This is exactly what happened to other promising small biotechs during the pandemic.

So the entire success or failure hinges on how well thought out the design of the "endpoints" are. Secondary endpoints do not matter.